Mathew Cherian

11PUBLICATIONS
51CO-AUTHORS
Molecular targetsLearning, motivation and emotionChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 27, 2025
Sulfatase 2 inhibition sensitizes triple-negative breast cancer cells to paclitaxel through augmentation of extracellular ATP.

Jasmine M Manouchehri, Jharna Datta, Lynn M Marcho

|Jun 24, 2023
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.

Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan

|Jun 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.

Sibel Blau, Julio Antonio Peguero, Halle C F Moore

|Jun 19, 2023
Worry and Mindfulness Differentially Impact Symptom Burden Following Treatment Among Breast Cancer Survivors: Findings From a Randomized Crossover Trial.

Megan E Renna, Annelise A Madison, Juan Peng

|Mar 21, 2023
Conflicts hurt: social stress predicts elevated pain and sadness after mild inflammatory increases.

Annelise A Madison, Megan Renna, Rebecca Andridge

Pageof 2